Michael Jelinek to Benzimidazoles
This is a "connection" page, showing publications Michael Jelinek has written about Benzimidazoles.
Connection Strength
0.751
-
A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101. Oral Oncol. 2021 03; 114:105171.
Score: 0.751